TUBEROUS SCLEROSIS COMPLEX (TSC)
Clinical trials for TUBEROUS SCLEROSIS COMPLEX (TSC) explained in plain language.
Never miss a new study
Get alerted when new TUBEROUS SCLEROSIS COMPLEX (TSC) trials appear
Sign up with your email to follow new studies for TUBEROUS SCLEROSIS COMPLEX (TSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human tests for multiple tumor types
Disease control Recruiting nowThis early-stage study is testing a new drug called Sapu003 in people with advanced cancers that have spread or cannot be removed by surgery. The main goal is to find the safest and most effective dose, and to see how the body processes the drug. The study includes 27 adults with…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX (TSC)
Phase: PHASE1 • Sponsor: SAPU NANO (US) LLC • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Cannabis extract trial offers new hope for controlling severe epilepsy
Disease control Recruiting nowThis study is testing whether a full-spectrum cannabis extract called YCJ-01 can safely reduce the number of seizures in people with Tuberous Sclerosis Complex (TSC) whose epilepsy is not controlled by standard treatments. It is a Phase 3 trial enrolling 84 participants, aged 2 t…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX (TSC)
Phase: PHASE3 • Sponsor: Oils4Cure • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC